Company news

Avalo Therapeutics, Inc. news in 2023

Avalo Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

December 26, 2023

Avalo Encourages Stockholders to Vote FOR the Reverse Stock Split

December 6, 2023

Avalo Reports Third Quarter 2023 Financial Results and Provides Business Updates

November 8, 2023

Avalo Completes Divestiture of AVTX-800 Series

October 30, 2023

Avalo Therapeutics Successfully Eliminates $35 Million Debt Paving the Way for Future Growth and Innovation

September 25, 2023

Avalo Enters into Agreement to Divest AVTX-800 Series

September 11, 2023

Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference

September 5, 2023

Avalo Reports Second Quarter 2023 Financial Results and Provides Business Updates

August 2, 2023

Avalo to Participate in SVB Securities Therapeutics Forum

July 5, 2023

Avalo Announces Topline Data from Phase 2 PEAK Trial for AVTX-002 (quisovalimab) in Patients with Non-Eosinophilic Asthma

June 25, 2023

Avalo to Present at the Jefferies Healthcare Conference

May 31, 2023

Avalo Announces Appointment of Michael Croft, Ph.D. and Jeff Edelson, M.D. to its Scientific Advisory Board

May 21, 2023

Avalo to Present at ATS 2023 Respiratory Innovation Summit

May 14, 2023

Avalo to Present at the 2023 RBC Capital Markets Global Healthcare Conference

May 9, 2023

Avalo Reports First Quarter 2023 Financial Results and Provides Business Updates

May 3, 2023

Avalo Reports 2022 Financial Results and Provides Business Updates

March 28, 2023

Avalo to Present at Oppenheimer's 33rd Annual Healthcare Conference

March 6, 2023

Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants

February 1, 2023

Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants

February 1, 2023

Avalo Announces it Has Completed Targeted Enrollment of 80 Patients in Phase 2 PEAK Trial of AVTX-002 in Non-Eosinophilic Asthma

January 16, 2023

Decks in 2023